| 摘要 |
Compounds of formula (I), in which X, A, B and C have the meanings given in Claim 1, as well as their salts, can be used as integrin inhibitors, in particular for the prevention and treatment of circulatory diseases, thrombosis, heart infarct, coronary heart diseases, arteriosclerosis, in pathological conditions maintained and propagated by angiogenesis, and for tumour therapy. |
